The Effects of Metronome Frequency Differentially Affects Gait on a Treadmill and Overground in People with Parkinson’s Disease - Wygand, Madelon; Chawla, Guneet; Browner, Nina; Lewek, Michael D (medRxiv, 2019)
Objective To determine the effect of different metronome cue frequencies on spatiotemporal gait parameters when walking overground compared to walking on a treadmill in people with Parkinson’s diseaseDesign Repeated-measures, within-subject designSetting Research laboratoryParticipants Twenty-one people with Parkinson’s disease (Hoehn & Yahr stage 1-3)Interventions Participants walked overground and on a treadmill with and without metronome cues of 85%, 100%, and 115% of their baseline cadence for one minute each.Main Outcome Measures Gait speed, step length, and cadenceResults An interaction effect between cue frequency and walking environment revealed that participants took longer steps during the 85% condition on the treadmill only. When walking overground, metronome cues of 85% and 115% of baseline cadence yielded decreases and increases, respectively, in both cadence and gait speed with no concomitant change in step length.Conclusions These data suggest that people with PD are able to alter spatiotemporal gait parameters immediately when provided the appropriate metronome cue and walking environment. We propose to target shortened step lengths by stepping to the beat of slow frequency auditory cues while walking on a treadmill, whereas the use of fast frequency cues during overground walking can facilitate faster walking speeds.Competing Interest StatementNina Browner has received travel and speaker fees from Parkinson Foundation and a grant for Parkinson Foundation Center of Excellence at University of North Carolina at Chapel Hill. For the remaining authors none were declared.Clinical TrialNCT03253965Funding StatementNo external funding was received for this study.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData will be made available upon request.PDParkinson’s diseaseH&YHoehn and YahrMoCAMontreal Cognitive AssessmentUPDRSUnified Parkinson’s Disease Rating ScaleANOVAAnalysis of Variance